Drug Topics February 2023

Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.

Viruses are known to precipitate autoimmune diseases, but the link between COVID-19 and autoimmune conditions requires additional research.

Anacaulase-bcdb improves current standard of care for deep partial thickness and/or full thickness thermal burns.

It’s not possible to phone it in to your job in community pharmacy.

The list prices of 450 medications have increased 5% overall, and more price hikes are expected.

Technology can streamline—and make safer—processes like medication reconciliation.

Researchers evaluated how changes in USP labeling standards have affected adherence across multiple classes of drugs.

RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe, and why has vaccine development taken so long?

Long, hot showers and cold, dry air can contribute to psoriasis flare-ups during the winter months.

Pharmaceutical companies are experiencing supply chain disruptions and shortages because of the popularity of diabetes drugs used for weight loss.

Results of a phase 3 clinical trial represent another avenue of treatment for children and adolescents living with type 2 diabetes.

To sufficiently address HIV, stakeholders across the health care spectrum must come together.

Keep your pharmacy services up to date with the latest 2023 ACIP vaccination schedule updates and recommendations.